Veracyte to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Veracyte (Nasdaq: VCYT) will participate in two upcoming investor events: the Canaccord Genuity 46th Annual Growth Conference in Boston, with a fireside chat on Tuesday, August 11 at 10:30 a.m. Eastern Time, and the Morgan Stanley 24th Annual Global Healthcare Conference in New York, with a fireside chat on Tuesday, September 15 at 5:35 p.m. Eastern Time. Live audio webcasts and 90-day replays for both presentations will be accessible via Veracyte’s investor relations website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will be participating in the following investor conferences:

• Canaccord Genuity 46^th Annual Growth Conference – Boston, MA
  Fireside chat on Tuesday, Aug 11^th at 10:30 a.m. Eastern Time

• Morgan Stanley 24^th Annual Global Healthcare Conference – New York, NY
  Fireside chat on Tuesday, Sep 15^th at 5:35 p.m. Eastern Time
  
  

Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at http://investor.veracyte.com/events-presentations. Replays of the webcasts will be available for 90 days after each live presentation broadcast.

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company with a vision to transform cancer care for patients around the world. The company’s molecular tests assess the unique biology of each patient’s tumor to help clinicians answer essential questions about cancer care. Veracyte’s Diagnostics Platform combines broad genomic and clinical data, advanced bioinformatics and AI, and a powerful evidence-generation engine to support continued innovation and pipeline development. The company’s portfolio includes the Afirma® Genomic Sequencing Classifier test, Decipher® Bladder Genomic Classifier test, Decipher® Prostate Genomic Classifier test, Prosigna® Breast Risk of Recurrence test, and the TrueMRD™ Monitoring Test for MIBC. For more information, visit Veracyte’s website or follow the company on LinkedIn or X (Twitter).

Investors:
Kelly Gura
investors@veracyte.com

Media:
Molly Cornbleet
media@veracyte.com
+1-650-351-8780

FAQ

When will Veracyte (VCYT) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

Veracyte is scheduled for a fireside chat on Tuesday, August 11, 2026, at 10:30 a.m. Eastern Time. According to Veracyte, a live audio webcast and 90-day replay will be available on its investor relations website.

What time is Veracyte’s (VCYT) presentation at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?

Veracyte plans a fireside chat on Tuesday, September 15, 2026, at 5:35 p.m. Eastern Time. According to Veracyte, investors can access a live webcast and 90-day replay through the company’s investor relations events page.

How can investors listen to Veracyte’s 2026 investor conference webcasts for VCYT?

Investors can access Veracyte’s live audio webcasts by visiting http://investor.veracyte.com/events-presentations. According to Veracyte, replays of each fireside chat will remain available on the site for 90 days after the live broadcasts.

Will replays of Veracyte’s (VCYT) 2026 Canaccord and Morgan Stanley presentations be available?

Yes, Veracyte plans to provide webcast replays for both conferences for 90 days. According to Veracyte, investors can find these replays on the company’s investor relations events and presentations webpage after each live session.

Where are the 2026 investor conferences featuring Veracyte (VCYT) being held?

Veracyte will present at the Canaccord Genuity conference in Boston, Massachusetts, and the Morgan Stanley Global Healthcare Conference in New York, New York. According to Veracyte, both events will also be accessible via online audio webcasts.